ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 40 of 60
JMBS 2019, 4(6): 271–277
Physical Therapy and Ergotherapy

The Effectiveness of Using Platelet–Rich Plasma in the Treatment of Patients with Spinal Osteochondrosis

Badyin I. Yu.

The purpose of the study was to evaluate the clinical efficacy of platelet–rich plasma for functional recovery in patients with vertebral neurological pathology. The study was carried out in the clinical department of the State Institution “Ukrainian Research Institute of Medical Rehabilitation and Balneology of the Ministry of Health of Ukraine” during 2016–2018. Material and methods. 115 patients with manifestations of widespread osteochondrosis of the spine with a primary lesion of the cervical and lumbosacral spine were examined. Patients were divided into two groups: the main (n = 85) group of patients who used platelet–rich plasma treatment and the control (n = 30) group with standard treatment with non–steroidal anti–inflammatory drugs (diclofenac 75 mg per day, injection route). The average age of patients included in the control group was 35.6±0.9 years. There were 18 (60.0 %) women and 12 (40.0 %) men in this group. There were younger patients in the main group. Their age was 20–45 years (n = 29, average age 33.4±1.1 years), a single administration of platelet–rich plasma was performed. Patients over the age of 45 years (n=56, average age 52.2±0.8 years) underwent repeated administration of platelet–rich plasma with an interval of 7–10 days between treatments. By gender composition, the main group was similar to the control one (there were 46women (54.1 %), and 39 men (45.9 %), p> 0.05). Results and discussion. In the group of patients treated with non–steroidal anti–inflammatory drugs after 3 days of observation, the pain decreased by 1.2±0.2 points on the visual–analog scale, and in the group for the use of platelet–rich plasma therapy, the pain intensity decreased by 0.6±0.1 point compared to baseline level. After 2 weeks of treatment, there was a significant decrease in the severity of pain according to the visual–analog scale in the control group by 2.1±0.2 points (p <0.05), and in the main group by 1.6±0.2 points (p <0.05). The results of a three–month observation of patients showed that the use of platelet–rich plasma therapy contributed to a decrease in pain according to the visual–analog scale to 2.0±0.2 points, which was on average 4 points less than the initial level (p <0.05). The described changes were accompanied by the increase in the spine mobility, as well as in the shoulder joints. These changes were more pronounced in patients treated with platelet–rich plasma. Shoulder abduction during the use of platelet–rich plasma increased from 78.6±4.3 to 160.3±9.5 in patients younger than 45 years and to 130.5±3.9 in older patients. The arm lift forward improved from 45.5±3.1 to 145.4±7.8 and 127.3±3.8, respectively. Conclusion. The obtained data illustrated the improvement in the performance of functional tests of the spine on the background of anti–inflammatory therapy, and in the group of patients who received platelet–rich plasma therapy, more stable positive dynamics were demonstrated. This allows us to recommend platelet–rich plasma therapy for widespread use in patients with vertebral neurological pathology.

Keywords: back pain, vertebral neurological pathology, functional recovery, treatment

Full text: PDF (Ukr) 443K

  1. Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012 Jun; 64(6): 2028–37.
  2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Aug 22; 386(9995): 743–800.–6736(15)60692–4
  3. Kigozi J, Konstantinou K, Ogollah R, Dunn K, Martyn L, Jowett S. Factors associated with costs and health outcomes in patients with Back and leg pain in primary care: a prospective cohort analysis. BMC Health Serv Res. 2019 Jun 21; 19(1): 406.–019–4257–0
  4. Sielski R, Rief W, Glombiewski JA. Efficacy of Biofeedback in Chronic back Pain: a Meta–Analysis. Int J Behav Med. 2017 Feb; 24(1): 25–41.–016–9572–9
  5. Tomchuk AG, Bogdanov AN. Reabylytatsyonnaya terapyya pry nevrologycheskykh syndromakh poyasnychnogo osteokhondroza [Rehabilitation therapy for neurological syndromes of lumbar osteochondrosis]. Ynnovatsyy v nauke. 2015; 41: 171–5. [Russian]
  6. Chebykyn AV, Mynasov TB, Nazarov AF. Ekspertnye voprosy v medytsynskoy reabylytatsyy vertebrologycheskykh patsyentov [Expert questions in the medical rehabilitation of vertebral patients]. Zdorove semy – 21 vek. 2016. № 1 (1). 104–21. [Russian]
  7. Charneux L, Demoulin C, Vanderthomment M, Tomasella M, Ferrara MA, Grosdent S, et al. [Platelet–rich plasma (PRP) and disc lesions: A review of the literature]. Neurochirurgie. 2017 Dec; 63(6): 473–7.
  8. Monfett M, Harrison J, Boachie–Adjei K, Lutz G. Intradiscal platelet–rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop. 2016 Jun; 40(6): 1321–8.–016–3178–3
  9. Zhulev NM, Badzgaradze YuD, Zhulev SN. Osteokhondroz pozvonochnyka [Osteochondrosis of the spine]. Rukovodstvo dlya vrachey. SPb: Yz–vo Lan; 2001. 592 s. [Russian]
  10. Behrend CJ, Schönbach EM, Vaccaro AR, Coyne E, Prasarn ML, Rechtine GR. Maximum pain on visual analog scales in spinal disorders. Spine J. 2017 Aug; 17(8): 1061–5.
  11. Shostak NA, Pravdyuk NG, Koryakyna YN. Bol v nyzhney chasty spyny u molodykh – novyy podkhod k terapyy [Lower back pain in young people is a new approach to therapy]. Terapevt arkh. 2009; 81(10): 52–5. [Russian]
  12. Borovykov VP, Borovykov YP. Statistica – Statystycheskyy analyz y obrabotka dannykh v srede Windows [Statistica - Statistical analysis and data processing in a Windows environment]. M: Ynformats–yzdat dom “Fylyn”; 1998. 608 s. [Russian]